BTEC - iShares Nasdaq US Biotechnology UCITS ETF (IE00BYXG2H39)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout

Enregistrer Fermer

(%)

IE00BYXG2H39

BTEC ISIN

Fonds négociés en bourse (FNB)

Type de fonds

BlackRock

Fournisseur

8,78 USD

valeur liquidative par action | 19/06/2026

19/10/2017

Date de lancement

Non

Paiement de dividendes

CEOGMS

CFI

BTEC

Ticker

Formed

Status

Equity

Objet d'investissement

Biotech

Secteur

USA

Géographie

Nasdaq Biotechnology Index

Benchmark

0.35 %

Ratio de coût total

949,7 mln USD

Actif total du fonds | 18/06/2026

Oui

UCITS

Dernières données pour

Ajouter à comparer

Cotations (BTEC)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

167 970

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

Screener d'obligations
liste de surveillance
Excel ADD-IN

Obtenir l'accès

Dynamique des prix

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEC profile

The iShares Nasdaq US Biotechnology UCITS ETF is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 19.10.2017 with unique ISIN - IE00BYXG2H39. Main exchange is London S.E. (USD) and ticker symbol is BTEC. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF pays dividends 0 time(s) per year.

Structure BTEC au 18/06/2026

Exporter la structure dans Excel

Titre	Valeur
VERTEX PHARMACEUTICALS INC	8,02%
AMGEN INC	7,97%
GILEAD SCIENCES INC	7,32%
REGENERON PHARMACEUTICALS INC	4,76%
ALNYLAM PHARMACEUTICALS INC	2,81%
REVOLUTION MEDICINES INC	2,63%
BIOGEN INC	2,2%
MODERNA INC	1,92%
ILLUMINA INC	1,86%
ARGENX SE ADR	1,84%
ROYALTY PHARMA PLC CLASS A	1,78%
UNITED THERAPEUTICS CORP	1,73%
ROIVANT SCIENCES LTD	1,71%
INSMED INC	1,57%
INCYTE CORP	1,49%
VIATRIS INC	1,36%
GUARDANT HEALTH INC	1,32%
NEUROCRINE BIOSCIENCES INC	1,21%
ASCENDIS PHARMA	1,08%
JAZZ PHARMACEUTICALS PLC	1,07%
MEDPACE HOLDINGS INC	1%
EXELIXIS INC	0,99%
BRIDGEBIO PHARMA INC	0,98%
AXSOME THERAPEUTICS INC	0,98%
IONIS PHARMACEUTICALS INC	0,93%
MADRIGAL PHARMACEUTICALS INC	0,88%
ARROWHEAD PHARMACEUTICALS INC	0,87%
CYTOKINETICS INC	0,81%
SUMMIT THERAPEUTICS INC	0,81%
BIOMARIN PHARMACEUTICAL INC	0,8%
BIONTECH SE ADR	0,8%
KRYSTAL BIOTECH INC	0,78%
SANOFI ADR REPRESENTING SA	0,75%
NUVALENT INC CLASS A	0,69%
BEONE MEDICINES AG	0,68%
TEMPUS AI INC CLASS A	0,67%
HALOZYME THERAPEUTICS INC	0,62%
PRAXIS PRECISION MEDICINES INC	0,6%
IMMUNITYBIO INC	0,58%
SPYRE THERAPEUTICS INC	0,58%
ALKERMES	0,57%
KYMERA THERAPEUTICS INC	0,56%
VAXCYTE INC	0,56%
PROTAGONIST THERAPEUTICS INC	0,55%
IMMUNOVANT INC	0,55%
RHYTHM PHARMACEUTICALS INC	0,5%
PTC THERAPEUTICS INC	0,5%
MIRUM PHARMACEUTICALS INC	0,5%
COGENT BIOSCIENCES INC	0,44%
ABIVAX AMERICAN DEPOSITARY SHARES	0,44%
SCHOLAR ROCK HOLDING CORP	0,43%
APOGEE THERAPEUTICS INC	0,42%
LIGAND PHARMACEUTICALS INC	0,42%
TWIST BIOSCIENCE CORP	0,41%
CG ONCOLOGY INC	0,41%
CARIS LIFE SCIENCES INC	0,4%
CRISPR THERAPEUTICS AG	0,4%
AMNEAL PHARMACEUTICALS INC CLASS A	0,39%
TRAVERE THERAPEUTICS INC	0,39%
XENON PHARMACEUTICALS INC	0,39%
CENTESSA PHARMACEUTICALS AMERICAN	0,38%
INDIVIOR PHARMACEUTICALS INC	0,35%
ORUKA THERAPEUTICS INC	0,33%
VERACYTE INC	0,32%
ERASCA INC	0,32%
10X GENOMICS INC CLASS A	0,31%
TANGO THERAPEUTICS INC	0,31%
EDGEWISE THERAPEUTICS INC	0,3%
CRINETICS PHARMACEUTICALS INC	0,29%
ACADIA PHARMACEUTICALS INC	0,28%
DENALI THERAPEUTICS INC	0,28%
BEAM THERAPEUTICS INC	0,27%
NEWAMSTERDAM PHARMA NV	0,26%
STRUCTURE THERAPEUTICS ADR INC	0,26%
RELAY THERAPEUTICS INC	0,26%
ARCUTIS BIOTHERAPEUTICS INC	0,25%
DYNE THERAPEUTICS INC	0,25%
ALUMIS INC	0,22%
UNIQURE NV	0,22%
ADAPTIVE BIOTECHNOLOGIES CORP	0,21%
IDEAYA BIOSCIENCES INC	0,21%
ENLIVEN THERAPEUTICS INC	0,21%
GRAIL INC	0,21%
TARSUS PHARMACEUTICALS INC	0,21%
DISC MEDICINE INC	0,2%
ULTRAGENYX PHARMACEUTICAL INC	0,2%
DEFINIUM THERAPEUTICS INC	0,2%
SUPERNUS PHARMACEUTICALS INC	0,2%
KINIKSA PHARMACEUTICALS INTERNATIO	0,19%
VERA THERAPEUTICS INC CLASS A	0,19%
TREVI THERAPEUTICS INC	0,19%
LEGEND BIOTECH ADR REP CORP	0,18%
KODIAK SCIENCES INC	0,18%
BIOCRYST PHARMACEUTICALS INC	0,18%
PHARVARIS N V NV	0,17%
INTELLIA THERAPEUTICS INC	0,17%
AURINIA PHARMACEUTICALS INC	0,16%
MINERALYS THERAPEUTICS INC	0,16%
AGIOS PHARMACEUTICALS INC	0,16%
MBX BIOSCIENCES INC	0,16%

Montrer tout Cacher

Autres - %

Autres actions de ce fonds

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)

Montrer tout

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

{{ item.etf.ttl }}

{{ item.nav_usd }} mln
Valeur nette d'actifs

{{ item.expense_ratio }}
Ratio de coût total